Subscribe to RSS
DOI: 10.1055/s-0032-1327348
Anti-inflammatorische Wirkungen der Tee-Flavonoide
Anti-inflammatory effects of tea-flavonoidsPublication History
Publication Date:
11 December 2012 (online)
![](https://www.thieme-connect.de/media/dmw/20125152/lookinside/thumbnails/10.1055-s-0032-1327348-1.jpg)
Zusammenfassung
Tee-Flavonoide gehören zu den Polyphenolen und haben antioxidative, antiinflammatorische und antineoplastische Eigenschaften. Diese Phytochemikalien sind körperfremde Substanzen und werden durch Teepflanzen synthetisiert (Botanicals). Sie haben zum Teil ähnliche Wirkungen wie die sogenannten Biologicals und hemmen immunologisch aktive Zellen und Cytokine. Kranke mit chronisch-entzündlich aktivierten Signalwegen könnten durch eine Behandlung mit Flavonoiden profitieren. Eine gesteigerte, diätetische Flavonoidzufuhr könnte als neue Therapie-Form bei Patienten mit chronisch entzündlichen Darmkrankheiten, Reizdarm sowie zur Prävention von intestinalen Neoplasien eingesetzt werden. Um diese neue Therapie-Form zu evaluieren sind Interventions-Studien im Sinne von kontrollierten randomisierten Klinischen Studien notwendig.
Abstract
Tea flavonoids belong to the large group of polyphenols and display antioxidative, anti-inflammatory and anti-neoplastic activities. These phytochemicals are xenobiotics and are synthesized by tea plants such as Camellia sinensis and Camomilla recucita. These botanicals exhibit in vivo activities similar to that of biologicals which are widely used for chronic inflammatory diseases (rheumatoid arthritis, chronic inflammatory bowel disease). Epigallocathechin gallate and apigenin from these plants inhibit cytokines, chemokines and activated immune cells in vivo and in vitro. Clinical disorders with induced inflammatory pathways could benefit from flavonoid treatment. Dietary supplementation with specific tea-flavonoids could be used for Crohn’s disease, ulcerative colitis and irritable bowel syndrome. Suppression of cytokine production could ultimately lead to inhibition of carcinogenesis. This mechanism could explain why flavonoids are effective in the prevention of intestinal neoplasia. This innovative new form of therapy should be tested in controlled, randomized clinical studies.
-
Literatur
- 1 Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143: 550-563
- 2 Desideri G, Kwik-Uribe C, Grassi D et al. Benefits in cognitive function, blood pressure,and insulin resistence through cocao flavanol consumption in elderly subjects with mild cognitive impairment. Hypertension 2012; 60: 794-801
- 3 Ellinger S, Müller N, Stehle P et al. Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies?. Phytomedicine 2011; 18: 903-915
- 4 Freitas S, Costa S, Azevedo C et al. Flavonoids inhibit angiogenic cytokine production by human glioma cells. Phytother Res 2011; 25: 916-921
- 5 Golomb BA, Koperski S, White HL. Association between more frequent chocolate consumption and lower body mass index. Arch Intern Med 2012; 172: 519-521
- 6 Han KC, Wong WC, Benzie IF. Genoprotective effects of green tea (Camellia sinensis) in human subjects: results of a controlled supplementation trial. Br J Nutr 2011; 105: 171-179
- 7 Hodgson JM, Puddey IB, Woodman RJ et al. Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med 2012; 172: 186-188
- 8 Hoensch HP, Kirch W. Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest Cancer 2005; 35: 187-195
- 9 Hoensch H, Groh B, Edler L et al. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol 2008; 14: 2187-2193
- 10 Hoensch HP, Oertel R. Emerging role of bioflavonoids in gastroenterology: Especially their effects on intestinal neoplasia. World J Gastrointest Oncol 2011; 3: 71-74
- 11 Hoensch H, Mueller D, Richling E. Down-regulation of inducble inflammatory genes of colon cancer cells by dietary tea-flavonoids. Naunyn Schmiedebergs Arch Pharmacol 2012; 385 (Suppl. 01) A.161: 38
- 12 Kim HK, Yang TH, Cho HY. Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol 2009; 15: 5200-5205
- 13 Mazzanti G, Menniti-Ippolito F, Moro PA et al. Hepatoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009; 65: 331-341
- 14 Moon H-S, Lee H-G, Choi Y-J et al. Proposed mechanisms of epigallo 3-cathechin gallate for anti-obesity. Chemico-Biological Interactions 2007; 167: 85-98
- 15 Rautiainen S, Larsson S, Virtamo J et al. Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women. Stroke 2012; 43: 335-340
- 16 Rink L, Kruse A, Haase H. Regulation des Immunsystems und immunpriviligierte Organe. In Immunologie für Einsteiger. Kapitel 7 Heidelberg: Spektrum Akademischer Verlag, Springer; 2012: 119-142
- 17 Romier B, Schneider YJ, Larondelle Y et al. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev 2009; 67: 363-378
- 18 Shapiro H, Singer P, Halpern Z et al. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 2007; 56: 426-435
- 19 Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res 2010; 27: 962-978
- 20 Stingl J, Ettrich T, Muche R et al. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE). BMC Cancer 2011; 11: 360-367
- 21 Visioli F. Polyphenol studies: time for a physiological tea party?. Br J Nutr 2011; 106: 1321-1322
- 22 Watzl B, Rechkemmer G. Flavonoide. Ernährungs-Umschau 2001; 48: 498-502